ANK2 | Ankyrin 2, neuronal | Cytoskeleton related proteins Disease related genes Plasma proteins Potential drug targets Transporters
| | | | | Mixed |
ANO6 | Anoctamin 6 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
ANXA1 | Annexin A1 | Cancer-related genes FDA approved drug targets Plasma proteins Transporters
| | | | | Expressed in all |
ANXA2 | Annexin A2 | Cancer-related genes Plasma proteins Transporters
| | | | | Expressed in all |
ANXA6 | Annexin A6 | Plasma proteins Transporters
| | | | | Expressed in all |
ASNA1 | ArsA arsenite transporter, ATP-binding, homolog 1 (bacterial) | Transporters
| | | | | Expressed in all |
ATP1B1 | ATPase, Na+/K+ transporting, beta 1 polypeptide | Predicted membrane proteins Transporters
| | | | | Expressed in all |
BAX | BCL2-associated X protein | Cancer-related genes Mitochondrial proteins Transporters
| | | | | Expressed in all |
BCAP29 | B-cell receptor-associated protein 29 | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
BCAP31 | B-cell receptor-associated protein 31 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
C1QBP | Complement component 1, q subcomponent binding protein | Cancer-related genes Mitochondrial proteins Plasma proteins Transporters
| | | | | Expressed in all |
CALM2 | Calmodulin 2 (phosphorylase kinase, delta) | Cancer-related genes Disease related genes Plasma proteins Potential drug targets RAS pathway related proteins Transporters
| | | | | Expressed in all |
CAV1 | Caveolin 1, caveolae protein, 22kDa | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CD9 | CD9 molecule | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
CD97 | CD97 molecule | CD markers G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
CLDN16 | Claudin 16 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
CLDN4 | Claudin 4 | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Mixed |
CLIC4 | Chloride intracellular channel 4 | Transporters
| | | | | Expressed in all |
COX4I1 | Cytochrome c oxidase subunit IV isoform 1 | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
CYBA | Cytochrome b-245, alpha polypeptide | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
DDX39B | DEAD (Asp-Glu-Ala-Asp) box polypeptide 39B | Enzymes Plasma proteins Transporters
| | | | | Expressed in all |
EIF4A3 | Eukaryotic translation initiation factor 4A3 | Disease related genes Enzymes Plasma proteins Potential drug targets Transporters
| | | | | Expressed in all |
ELTD1 | EGF, latrophilin and seven transmembrane domain containing 1 | G-protein coupled receptors Plasma proteins Predicted membrane proteins Transporters
| | | | | Mixed |
FABP5 | Fatty acid binding protein 5 (psoriasis-associated) | Cancer-related genes Plasma proteins Transporters
| | | | | Expressed in all |
FXYD5 | FXYD domain containing ion transport regulator 5 | Plasma proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
GAP43 | Growth associated protein 43 | Plasma proteins Transporters
| | | | | Tissue enriched |
LAMP1 | Lysosomal-associated membrane protein 1 | CD markers Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
LAMP2 | Lysosomal-associated membrane protein 2 | CD markers Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
MAGOH | Mago-nashi homolog, proliferation-associated (Drosophila) | Transporters
| | | | | Expressed in all |
MS4A1 | Membrane-spanning 4-domains, subfamily A, member 1 | CD markers Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
MT-CO3 | Mitochondrially encoded cytochrome c oxidase III | Disease related genes Mitochondrial proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
NCBP1 | Nuclear cap binding protein subunit 1, 80kDa | Transporters
| | | | | Expressed in all |
NCBP2 | Nuclear cap binding protein subunit 2, 20kDa | Transporters
| | | | | Expressed in all |
OCLN | Occludin | Disease related genes Potential drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Mixed |
OXA1L | Oxidase (cytochrome c) assembly 1-like | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
PNN | Pinin, desmosome associated protein | Transporters
| | | | | Expressed in all |
PSAP | Prosaposin | Disease related genes Plasma proteins Potential drug targets Predicted secreted proteins Transporters
| | | | | Expressed in all |
PSEN1 | Presenilin 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC16A2 | Solute carrier family 16, member 2 (thyroid hormone transporter) | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Mixed |
SLC16A3 | Solute carrier family 16 (monocarboxylate transporter), member 3 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC2A1 | Solute carrier family 2 (facilitated glucose transporter), member 1 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC2A3 | Solute carrier family 2 (facilitated glucose transporter), member 3 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC30A1 | Solute carrier family 30 (zinc transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Mixed |
SLC35F1 | Solute carrier family 35, member F1 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC38A7 | Solute carrier family 38, member 7 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC50A1 | Solute carrier family 50 (sugar efflux transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC9A1 | Solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC9A3R1 | Solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1 | Disease related genes Plasma proteins Potential drug targets Transporters
| | | | | Expressed in all |
SLC9A3R2 | Solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 2 | Transporters
| | | | | Mixed |
SMDT1 | Single-pass membrane protein with aspartate-rich tail 1 | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |